ANTIBODY FOR MULTIPLE HUMAN T-LYMPHOTROPIC VIRUSES (HTLV) - ANVISA Registration 80146501605

Access comprehensive regulatory information for ANTIBODY FOR MULTIPLE HUMAN T-LYMPHOTROPIC VIRUSES (HTLV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80146501605 and manufactured by manufacturer not specified. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until Sep 14, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, QUIBASA QUÍMICA BÁSICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80146501605
2 Related Devices
Registration Details
ANVISA Registration Number: 80146501605
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

ARCHITECT rHTLV-I/II Reagent Kit / ARCHITECT rHTLV-I/II Kit Reagente
Risk Class IV

Registration Details

80146501605

25351057080200920

56998701000116

Company Information

Dates and Status

Sep 14, 2009

14/09/2034

09/18/2025 19:00:01

ARCHITECT rHTLV-I/II Reagent Kit / ARCHITECT rHTLV-I/II Kit Reagente
Risk Class IV

Registration Details

80146501605

25351057080200920

56998701000116

Company Information

ABBOTT GMBH
Germany
PT: ALEMANHA

Dates and Status

Sep 14, 2009

14/09/2034

09/18/2025 19:00:01